Especially in cases with mesenchymal tumors that show neural and smooth muscle differentiation, the interpretation of pan-Trk IHC should be considered due to physiological cytoplasmic expression of pan-Trk in neural and smooth muscle tissue and their malignant counterparts [14,35,36]. Here, TPM3 is linked to mesenchymal cell neoplasm.